Back

Incorporation of TRDV segments into TCR alpha chains

Volkmar, M.; Fakhr, E.; Zens, S.; Offringa, R.; Bury, A.; Gordon, J.; Huduti, E.; Woelfel, T.; Woelfel, C.

2023-02-27 immunology
10.1101/2023.02.26.530072 bioRxiv
Show abstract

In human tumor models we tried to identify and clone the TCR of tumor-reactive T cells enriched in mixed lymphocyte tumor-cell cultures (MLTC). In a particular MLTC, we identified a predominant TCR beta chain using the Beta Mark Vbeta Kit, but a corresponding alpha chain could not be amplified via RT-PCR using TRAV-specific forward primers. Therefore, we applied 5RACE to obtain the TCR alpha chain sequences. The 5RACE product revealed an alpha chain that encompassed 89bp of the TRDV1 5UTR, followed by the TRDV1 coding sequence joined in frame to TRAJ24. The ORF reaching from the TRDV1 start codon to the TRAC segment was intact, suggesting a functional TCR. To analyze this MLTC population in greater depth we conducted 10X VDJ sequencing. CellRanger identified the beta chain known from the Beta Mark analysis, but no corresponding alpha chain in the filtered results. The corresponding TRDV-containing TCR alpha chain could, however, be detected in the "all_contig_annotations" files. In a separate project, we performed TCR sequencing of tumor-infiltrating lymphocytes (TILs) in a murine tumor model. Also here, a predominant clonotype contained a TCR alpha chain joining Trdv2-2 in frame to Traj49. Transfection of both TCR cDNAs resulted in cell surface localization of TCR and CD3 as validated by FACS. Tumor recognition of the human, TRDV1-containing TCR could be demonstrated by IFNgamma ELISpot whereas the murine TCR did not recognize a tumor-derived cell line. TRDV-containing alpha chains have been reported in the literature for two HLA I-restricted TCRs against HIV peptides (Ueno et al, Eur J Immunol, 2003). To determine whether such TDRV-containing TCRs are unique events or whether Vdelta segments are commonly incorporated into TCR alpha chains, we queried the NCBI Sequence Read Archive (SRA) for 10X VDJ data and analyzed 21 human and 23 murine datasets. We found that especially TRDV1, Trdv1 and to some extent Trdv2-2 are more commonly incorporated into TCR alpha chains than some TRAV genes, making the TRDV segments a relevant contribution to TCR alpha diversity. For apparently solitary beta chains in 10X VDJ datasets, we suggest to scrutinize the "all_contig_annotations" files as these may contain an accompanying, TRDV-containing alpha chain.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Molecular Immunology
14 papers in training set
Top 0.1%
18.8%
2
Frontiers in Immunology
586 papers in training set
Top 0.1%
18.8%
3
Scientific Reports
3102 papers in training set
Top 6%
10.2%
4
European Journal of Immunology
57 papers in training set
Top 0.1%
4.0%
50% of probability mass above
5
Journal of Virology
456 papers in training set
Top 2%
3.1%
6
iScience
1063 papers in training set
Top 6%
3.1%
7
PLOS ONE
4510 papers in training set
Top 43%
2.9%
8
Cells
232 papers in training set
Top 1%
2.1%
9
Journal of Immunological Methods
24 papers in training set
Top 0.1%
1.9%
10
Immunology
29 papers in training set
Top 0.4%
1.7%
11
eLife
5422 papers in training set
Top 45%
1.5%
12
PLOS Pathogens
721 papers in training set
Top 7%
1.3%
13
OncoImmunology
22 papers in training set
Top 0.2%
1.3%
14
International Journal of Molecular Sciences
453 papers in training set
Top 12%
1.0%
15
Viruses
318 papers in training set
Top 4%
0.9%
16
Virus Research
36 papers in training set
Top 1.0%
0.9%
17
The Journal of Immunology
146 papers in training set
Top 1%
0.9%
18
Cell Reports
1338 papers in training set
Top 30%
0.9%
19
Cancers
200 papers in training set
Top 4%
0.9%
20
Vaccines
196 papers in training set
Top 3%
0.8%
21
Communications Biology
886 papers in training set
Top 23%
0.8%
22
Frontiers in Genetics
197 papers in training set
Top 9%
0.8%
23
PLOS Computational Biology
1633 papers in training set
Top 24%
0.8%
24
Nature Communications
4913 papers in training set
Top 62%
0.8%
25
Immunology & Cell Biology
11 papers in training set
Top 0.4%
0.7%
26
Biomedicines
66 papers in training set
Top 4%
0.7%
27
Frontiers in Physiology
93 papers in training set
Top 8%
0.5%
28
Frontiers in Oncology
95 papers in training set
Top 4%
0.5%
29
F1000Research
79 papers in training set
Top 7%
0.5%